PMD Device Solutions Investor Relations Material
Latest events
Q4 2022
PMD Device Solutions
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from PMD Device Solutions
Access all reports
Promore Pharma AB, a biopharmaceutical company, develops therapeutic peptides for the bio-active wound care market in Sweden and internationally. The company offers Promogran Prisma, a collagen-based matrix; RESTORE collagen matrix, a synthetic medical device; PromoFoam matrix, a calcium alginate wound dressing; PAH250 Woundhance, a pharmaceutical agent used in the treatment of chronic wounds; and CytoMend, a resorbable extracellular matrix. It is also developing Platelet Rich Plasma (PRP), which has new functions for patients with chronic wounds; and Aktipak, which is indicated for treating acute deep wounds in conjunction with surgery/suture and debridement/wound bed preparation.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
PMDS
Country
🇸🇪 Sweden